Dalpiciclib (SHR-6390) is an orally active and highly selective inhibitor of CDK4 and 6 with IC50 values of 12.4 nM and 9.9 nM, respectively[1][2]. Dalpiciclib shows antitumor activity against breast cancer and esophageal squamous cell carcinoma[1][2][3][4].
Molecular Weight:
446.54
Purity:
99.70
CAS Number:
[1637781-04-4]
Formula:
C25H30N6O2
Target:
CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted